CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Nanobiotix Sa Company Snapshot
Nanobiotix Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nanobiotix Sa with three other miscellaneous service companies in Europe: Deutsche Biotech Innovativ AG of Germany (2018 sales of 127,105.72 Euro [US$141,386.05 ] ), Synairgen PLC of the United Kingdom (£105,000.00 [US$138,522.30 ] of which 100% was Drug Discovery), and Fluicell AB which is based in Sweden (1.23 million Swedish Kronor [US$130,532.22 ] ).

Sales Analysis. During the year ended December of 2018, sales at Nanobiotix Sa were 116,000.00 Euro (US$129.03 thousand). This is a sharp decrease of 54.0% versus 2017, when the company's sales were 251,968.00 Euro. Contributing to the drop in overall sales was the 69.8% decline in Other Sales, from 23,205.00 Euro to 7,000.00 Euro. There were also decreases in sales in Services (down 52.3% to 109,000.00 Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Nanobiotix Sa
  Stock Performance Chart for Nanobiotix Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 7.72
(Figures in Euro)
1 Week 2.6%   13 Weeks 10.0%  
4 Weeks -15.4%   52 Weeks -39.8%  
 
Nanobiotix Sa Key Data:
  Ticker: NANO Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 116,000
(Year Ending Jan 2019).
Employees: 102
  Currency: Euro Market Cap: 172,517,829
  Fiscal Yr Ends: December Shares Outstanding: 22,346,869
  Share Type: Ordinary Closely Held Shares: 731,560
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.